Physiological and electrophysiological evaluation of the hearing system in low birth weight neonates treated with cholestin: a cohort study

[1]  S. Villullas,et al.  Colistin- and Amikacin-loaded lipid-based drug delivery systems for resistant gram-negative lung and wound bacterial infections. , 2023, International journal of pharmaceutics.

[2]  Chanapai Chaiyakulsil,et al.  Hearing screening outcomes in pediatric critical care survivors: a 1-year report , 2022, Acute and critical care.

[3]  Yuan F. Liu,et al.  Drug‐Induced Ototoxicity: A Comprehensive Review and Reference Guide , 2020, Pharmacotherapy.

[4]  Sherman Lord.  Monitoring Protocols for Cochlear Toxicity , 2019, Seminars in Hearing.

[5]  Mulunesh Alemayehu,et al.  Magnitude of Low Birth Weight and Associated Factors among Newborns Delivered in Dangla Primary Hospital, Amhara Regional State, Northwest Ethiopia, 2017 , 2019, Journal of pregnancy.

[6]  N. Schellack,et al.  Prevention of treatment-induced ototoxicity: An update for clinicians , 2019, South African Medical Journal.

[7]  Selman Sarıca,et al.  An evaluation of hearing in infants administered with colistin in the premature neonatal intensive care unit , 2018, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[8]  V. Manchaiah,et al.  Ototoxicity: A Challenge in Diagnosis and Treatment , 2018, Journal of audiology & otology.

[9]  Evrim Kıray Baş,et al.  Use of Colistin in a Neonatal Intensive Care Unit: A Cohort Study of 65 Patients , 2017, Medical science monitor : international medical journal of experimental and clinical research.

[10]  P. Lopez,et al.  Auditory Brainstem Response in Term and Preterm Infants with Neonatal Complications: The Importance of the Sequential Evaluation , 2014, International Archives of Otorhinolaryngology.

[11]  R. Polin.  Management of Neonates With Suspected or Proven Early-Onset Bacterial Sepsis , 2012, Pediatrics.

[12]  V. Manchanda,et al.  Intravenous Colistin Administration in Neonates , 2011, The Pediatric infectious disease journal.

[13]  Mirjana Lulic‐Botica,et al.  Colistin Therapy in a 23-Week Gestational-Age Neonate with Multidrug-Resistant Acinetobacter baumannii Pneumonia , 2011, American Journal of Perinatology Reports.

[14]  A. Eddins,et al.  In utero iron status and auditory neural maturation in premature infants as evaluated by auditory brainstem response. , 2010, The Journal of pediatrics.

[15]  M. Falagas,et al.  Toxicity of polymyxins: a systematic review of the evidence from old and recent studies , 2006, Critical care.

[16]  P. Kazembe,et al.  Neonatal sepsis: an international perspective , 2005, Archives of Disease in Childhood - Fetal and Neonatal Edition.

[17]  J. Hibbard,et al.  Reducing the frequency of low birth weight in the United States. , 1994, Obstetrics and gynecology.

[18]  F. Arias,et al.  Etiology and Outcome of Low Birth Weight and Preterm Infants , 1982, Obstetrics and gynecology.

[19]  S. Yurttutan,et al.  Short and long term side effect of colistin treatment in preterm infants. , 2021, The Turkish journal of pediatrics.

[20]  Shan Sun,et al.  Protection of Hair Cells from Ototoxic Drug-Induced Hearing Loss. , 2019, Advances in experimental medicine and biology.

[21]  W James,et al.  New Handbook Of Auditory Evoked Responses >>>CLICK HERE<<< , 2007 .

[22]  W. Hop,et al.  Newborn hearing screening: tobramycin and vancomycin are not risk factors for hearing loss. , 2003, The Journal of pediatrics.

[23]  V. Pierrat,et al.  [Contribution to the definition of high-risk groups of low birth weight infants]. , 1989, Revue d'epidemiologie et de sante publique.